Article
CRISPR/Cas9 for Cancer Therapy: Hopes and Challenges
12 Nov 2018
Abstract excerpt
Cancer is the second leading cause of death globally and remains a major economic and social burden. Although our understanding of cancer at the molecular level continues to improve, more effort is needed to develop new therapeutic tools and approaches exploiting these advances. Because of its high efficiency and accuracy, the CRISPR-Cas9 genome editing technique has recently emerged as a potentially powerful...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
